Could less radiation after surgery keep throat cancer in check with fewer side effects?

NCT ID NCT05387915

First seen Apr 01, 2026 · Last updated May 16, 2026 · Updated 5 times

Summary

This study is for people with HPV-positive throat cancer, a type that usually responds well to treatment. After robotic surgery to remove the tumor, participants receive a lower dose of radiation than the standard amount. The goal is to see if this gentler approach can still control the cancer while reducing long-term problems like trouble swallowing, improving quality of life. About 33 adults are taking part in this phase 2 trial.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Emory University Hospital/Winship Cancer Institute

    Atlanta, Georgia, 30322, United States

  • Emory University Midtown Hospital

    Atlanta, Georgia, 30308, United States

  • Vanderbilt University Medical Center

    Nashville, Tennessee, 37232, United States

Conditions

Explore the condition pages connected to this study.